Wenfeng Fang
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 10%
- Cancer Research top 2%
- Immunology top 5%
- Co-authors
- Shaodong HongYan HuangYunpeng YangHongyun ZhaoYuxiang MaLi ZhangJianhua ZhanYaxiong Zhang
- Topics
- Lung Cancer Treatments and Mutations (120 papers)Cancer Immunotherapy and Biomarkers (58 papers)Lung Cancer Research Studies (48 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wenfeng Fang
191 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 2.4k
- Molecular Biology 1.1k
- Cancer Research 890
- Immunology 681
Countries citing papers authored by Wenfeng Fang
This map shows the geographic impact of Wenfeng Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Fang more than expected).
Fields of papers citing papers by Wenfeng Fang
This network shows the impact of papers produced by Wenfeng Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Fang. The network helps show where Wenfeng Fang may publish in the future.
Co-authorship network of co-authors of Wenfeng Fang
This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Fang. A scholar is included among the top collaborators of Wenfeng Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Fang. Wenfeng Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 23 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 34 | |
| 12 | 15 | |
| 13 | 1 | |
| 14 | 9 | |
| 15 | 32 | |
| 16 | 11 | |
| 17 | 15 | |
| 18 | 139 | |
| 19 | 18 | |
| 20 | 10 |
About Wenfeng Fang
Wenfeng Fang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 201 papers that have together received 4.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (120 papers), Cancer Immunotherapy and Biomarkers (58 papers) and Lung Cancer Research Studies (48 papers). The work is most often cited by research in Oncology (3.4k citations), Pulmonary and Respiratory Medicine (2.4k citations) and Otorhinolaryngology (277 citations). Wenfeng Fang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shaodong Hong, Yan Huang, Yunpeng Yang, Hongyun Zhao, Yuxiang Ma, Li Zhang, Jianhua Zhan, Yaxiong Zhang, Li Zhang and Yuanyuan Zhao. Their work appears in journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.